Representative Jefferson Shreve (R-Indiana) recently sold shares of Stryker Corporation NYSE: SYK. In a filing disclosed on June 22nd, the Representative disclosed that they had sold between $50,001 and $100,000 in Stryker stock on May 12th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.
Representative Jefferson Shreve also recently made the following trade(s):
- Sold $15,001 - $50,000 in shares of Hubbell NYSE: HUBB on 5/12/2025.
- Sold $50,001 - $100,000 in shares of Trane Technologies NYSE: TT on 5/12/2025.
- Sold $15,001 - $50,000 in shares of RTX NYSE: RTX on 5/12/2025.
- Sold $50,001 - $100,000 in shares of NiSource NYSE: NI on 5/12/2025.
- Sold $50,001 - $100,000 in shares of Johnson & Johnson NYSE: JNJ on 5/12/2025.
- Sold $15,001 - $50,000 in shares of AppLovin NASDAQ: APP on 5/12/2025.
- Sold $15,001 - $50,000 in shares of Fiserv NYSE: FI on 5/12/2025.
- Sold $15,001 - $50,000 in shares of CNO Financial Group NYSE: CNO on 5/12/2025.
- Sold $50,001 - $100,000 in shares of Cboe Global Markets NASDAQ: CBOE on 5/12/2025.
- Sold $15,001 - $50,000 in shares of Lam Research NASDAQ: LRCX on 5/12/2025.
Stryker Trading Up 1.7%
NYSE:SYK traded up $6.68 during mid-day trading on Friday, hitting $403.34. The company had a trading volume of 963,567 shares, compared to its average volume of 1,093,202. Stryker Corporation has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The business's fifty day moving average is $386.37 and its two-hundred day moving average is $379.44. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64. The firm has a market cap of $153.95 billion, a P/E ratio of 54.51, a P/E/G ratio of 2.99 and a beta of 0.91.
Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating the consensus estimate of $2.73 by $0.11. The firm had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The company's quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.50 earnings per share. As a group, research analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.
Stryker Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be paid a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.83%. The ex-dividend date is Monday, June 30th. Stryker's dividend payout ratio (DPR) is presently 45.41%.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the company. Citigroup reiterated a "buy" rating and set a $455.00 price objective (up from $443.00) on shares of Stryker in a report on Thursday, May 22nd. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a research report on Monday, May 5th. Roth Mkm boosted their price target on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research report on Friday, May 2nd. Sanford C. Bernstein set a $450.00 price target on Stryker in a research report on Monday, May 5th. Finally, BTIG Research reaffirmed a "buy" rating on shares of Stryker in a research report on Monday, July 14th. Four analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $428.55.
Get Our Latest Research Report on Stryker
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of SYK. NorthRock Partners LLC raised its holdings in shares of Stryker by 0.3% during the 2nd quarter. NorthRock Partners LLC now owns 15,986 shares of the medical technology company's stock worth $6,324,000 after buying an additional 41 shares in the last quarter. Envestnet Portfolio Solutions Inc. raised its holdings in shares of Stryker by 8.7% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 11,185 shares of the medical technology company's stock worth $4,425,000 after buying an additional 899 shares in the last quarter. Oregon Public Employees Retirement Fund raised its holdings in shares of Stryker by 0.7% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 29,725 shares of the medical technology company's stock worth $11,760,000 after buying an additional 200 shares in the last quarter. Concord Asset Management LLC VA acquired a new position in shares of Stryker during the 2nd quarter worth $382,000. Finally, Sequoia Financial Advisors LLC raised its holdings in shares of Stryker by 4.6% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 12,962 shares of the medical technology company's stock worth $5,128,000 after buying an additional 572 shares in the last quarter. Institutional investors and hedge funds own 77.09% of the company's stock.
Insider Activity at Stryker
In related news, Director Ronda E. Stryker sold 200,000 shares of the business's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the sale, the director owned 3,417,326 shares in the company, valued at $1,288,195,208.96. The trade was a 5.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 5.20% of the company's stock.
About Representative Shreve
Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election.
Email editor@ballotpedia.org to notify us of updates to this biography.
Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive.
Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.
About Stryker
(
Get Free Report)
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Read More
Before you consider Stryker, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.
While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
